Profound Medical Corp. — Company profile
Healthcare · Medical Devices · Canada
Last price 5.86 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 214.50M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Profound Medical Corp. operates as a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapeutic systems for the image guided ablation of diseased tissue. The company’s lead product TULSA-PRO system combines magnetic resonance imaging (MRI), robotically driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. It also provides Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. It operates in Canada, Germany, the United States, China, and Finland. Profound Medical Corp. is headquartered in Mississauga, Canada.
Details
| Name | Profound Medical Corp. |
| Sector | Healthcare |
| Industry | Medical Devices |
| Employees | 162 |
| Ceo | Arun Menawat |
| Country | Canada |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Isin | CA74319B5027 |
| Cusip | 74319B502 |
| Cik | 1628808 |
| Sic | 3841 |
Key executives
| Name | Title |
|---|---|
| Dr. Arun Swarup Menawat MBA, Ph.D. | Chairman of the Board and Chief Executive Officer |
| Dr. Mathieu Burtnyk Ph.D. | Chief Technology Officer |
| Thomas Tamberrino MBA | Chief Commercial Officer |
| Richard R. Fabian | President |
| Matthew Sobczyk C.A., CPA | Interim Chief Financial Officer |
| Stephen Kilmer | Investor Relations |
| Levant Tinaz | Software Developer |
Contact
| Address | 2400 Skymark Avenue, Unit 6, Mississauga, ON L4W 5K5, Canada |
| Phone | 647 476 1350 |
| Website | https://www.profoundmedical.com |